Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023530 · ClinicalTrials.gov registry record · NA
Blood and Marrow Transplant Clinical Research Network
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
NCT00023530 is a NA study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI).
The verdict
NCT00023530, a NA study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
Interventions
- DRUG dexamethasone
- DRUG thalidomide
- DRUG fluconazole
- DRUG voriconazole
- PROCEDURE bone marrow transplant
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-09 |
| Est. Completion | 2006-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023530
The ClinicalTrials.gov registry entry for NCT00023530 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which dexamethasone is the first listed.
NCT00023530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00023530 about?
NCT00023530 is a clinical study titled "Blood and Marrow Transplant Clinical Research Network". The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
What is the current status of trial NCT00023530?
This trial is currently completed. It is a NA study. The study started on 2001-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00023530?
The interventions under investigation include: dexamethasone (DRUG), thalidomide (DRUG), fluconazole (DRUG), voriconazole (DRUG), bone marrow transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00023530?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.